Immunohistochemical assessment of lymphovascular invasion in stage i colorectal carcinoma: Prognostic relevance and correlation with nodal micrometastases

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 66-72

  Barresi, Valeria ^a   Reggiani Bonetti, Luca ^b   Vitarelli, Enrica ^a   Di Gregorio, Carmela ^b   Ponz De Leon, Maurizio ^c   Barresi, Gaetano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Anatomic Pathology and Legal Medicine ^*  (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

D2 40; lymphatic vessel density; lymphovascular invasion; micrometastases; stage I colorectal carcinoma

Indexed keywords

DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40;

ADENOCARCINOMA; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COLORECTAL TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; MICROMETASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84355166632     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822d3008     Document Type: Article

References (32)

1. Adachi Y, Nakamura H, Kitamura Y, et al. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph nodemetastases. Pathol Int. 2007;57:171-177. (Pubitemid 46279944)
2. Arigami T, Natsugoe S, Uenosono Y, et al. Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer. 2005;93:688-693. (Pubitemid 41486460)
3. Arnaout-Alkarain A, Kahn HJ, Narod SA, et al. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol. 2007;20:183-191. (Pubitemid 46422172)
4. Barresi V, Reggiani-Bonetti L, Di Gregorio C, et al. Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol. 2011;64:6-12.
5. Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum. 1997;40:1465-1471. (Pubitemid 27528286)
6. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum. 1991;34:917-920.
7. Di Gregorio C, Fante R, Roncucci L, et al. Clinical features, frequency and prognosis of Dukes' A colorectal carcinoma: a population-based investigation. Eur J Cancer. 1996;32A:1957-1962. (Pubitemid 26361691)
8. Gao J, Knutsen A, Arbman G, et al. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Digest Liv Dis. 2009;41:116-122.
9. Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res. 1999;5:1950-1960. (Pubitemid 29399243)
10. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994;73:563-569. (Pubitemid 24046594)
11. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet. 1995;345:1257-1259.
12. Iddings D, Ahmad A, Elashoff D, et al. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol. 2006;13: 1386-1392. (Pubitemid 44749649)
13. Jeffers MD, O'Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micro-metastases in colorectal carcinoma. J Pathol. 1994;172:183-187. (Pubitemid 24098670)
14. Keene SA, Demeure MJ. The clinical significance of micrometa-stases and molecular metastases. Surgery. 2001;129:1-5. (Pubitemid 32099250)
15. Landis SH, Murray T, Bolden S. Cancer statistics. Cancer J Clin. 1999;49:8-31.
16. Lee MR, Hong CW, Yoon SN, et al. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer. J Surg Oncol. 2006;93:13-18. (Pubitemid 43038419)
17. Liang P, Nakada I, Hong JW, et al. Prognostic significance of immunohistochemically detected blood and lymphaticvessel invasion in colorectal carcinoma: its impact on prognosis. Ann Surg Oncol. 2006;14:470-477. (Pubitemid 46175291)
18. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micro-metastases and survival in stage II colorectal cancer. N Engl J Med. 1998;339:223-228. (Pubitemid 28350164)
19. Lin M, Ma SP, Lin HZ, et al. Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavorable outcome in colorectal cancer. Clin Exp Metastasis. 2010;27:123-132.
20. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001;20:672-682. (Pubitemid 32167632)
21. Nicastri DG, Doucette JT, Godfrey TE, et al. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn. 2007;9:563-571. (Pubitemid 350158413)
22. Reggiani Bonetti L, Di Gregorio C, De Gaetani C, et al. Lymph node micrometastasis and survival of patients with stage I (Dukes' A) colorectal carcinoma. Scand J Gastroenterol. 2011. Epub ahead of print.
23. Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: what do we know? Microsc Res Tech. 2003;60:171-180. (Pubitemid 36125705)
24. Rosenberg R, Hoos A, Mueller J, et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node negative colorectal cancer patients. J Clin Oncol. 2002;20:1049-1055. (Pubitemid 34144594)
25. Sasaki M, Watanabe H, Jass JR. Occult lymph node meta-stases detected by cytokeratin immunohistochemisty predict recurrence in "node-negative" colorectal cancer. J Gastroenterol. 1997;32: 758-764. (Pubitemid 27524981)
26. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors International Union Against Cancer (UICC). 6th edn. New York: Wiley-Liss; 2002.
27. Stacker S, Baldwin ME, Achen MG. The role of tumor lymphan-giogenesis in metastatic spread. FASEB J. 2002;16:922-934. (Pubitemid 34753498)
28. Van der Auwera I, Van den Eynden GG, Colpaert CG, et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res. 2005;11:7637-7642. (Pubitemid 41611604)
29. Wiggers T, Arends JW, Schutter B, et al. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer. 1988;61:386-389.
30. Wu XC, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group. Cancer. 2001;92:2547-2554. (Pubitemid 33049437)
31. Yamamoto N, Kato Y, Yanagisawa A, et al. Predictive value of genetic diagnosis for cancer micrometastasis: histologic and experimental appraisal. Cancer. 1997;80:1393-1398. (Pubitemid 27441012)
32. Zetter BR. The cellular basis of site-specific tumor metastasis. N Engl J Med. 1990;322:605-612. (Pubitemid 20190796)